UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of immunocytology to predict bladder cancer presence in patients with asymptomatic hematuria

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.242-242

2011

Volltextzugriff (PDF)

WISER survivor: Exercise and/or weight loss in breast cancer survivors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS10140-TPS10140

2016

Volltextzugriff (PDF)

Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9044-9044

2016

Volltextzugriff (PDF)

Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7574-7574

2018

Volltextzugriff (PDF)

Impact of older age on chemotherapy toxicity and quality of life in women with advanced or recurrent cervical cancer: A NRG Oncology-GOG Ancillary Study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5604-5604

2015

Volltextzugriff (PDF)

First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8013-8013

2015

Volltextzugriff (PDF)

Aggressive craniofacial lymphoma in the pre-rituximab and rituximab era

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8038-8038

2011

Volltextzugriff (PDF)

Evidence for rituximab (R) underdosing in subpopulations of elderly patients with DLBC: Results of the RICOVER-60 study of the DSHNHL

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8024-8024

2012

Volltextzugriff (PDF)

Identification of 46 quality indicators for cancer care in office-based oncology practices in Germany

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16514-e16514

2011

Volltextzugriff (PDF)

The impact of high-intensity conditioning prior to allogeneic stem cell transplantation in patients with chemorefractory or relapsed T-cell lymphoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8040-8040

2011

Volltextzugriff (PDF)

Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8004-8004

2011

Volltextzugriff (PDF)

Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20 + B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8029-8029

2011

Volltextzugriff (PDF)

Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: Final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphona Study Group (DSHNHL)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8002-8002

2011

Volltextzugriff (PDF)

Prevention of palmoplantar erythrodysesthesia (PPE) with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (PLD), a placebo-controlled, double blinded, phase lll trial (SAKK 92/08)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.9059-9059

2012

Volltextzugriff (PDF)

Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8005-8005

2010

Volltextzugriff (PDF)

Mature T-/NK-cell lymphomas: Prognostic factors and treatment outcome of patients treated on studies of the German High-Grade Lymphoma Study Group (DSHNHL)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8564-8564

2009

Volltextzugriff (PDF)

R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8509-8509

2009

Volltextzugriff (PDF)

Prophylactic oral glutamine for docetaxel or paclitaxel associated taste alterations in cancer patients: A randomised, parallel, placebo-controlled, double-blind study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.9104-9104

2007

Volltextzugriff (PDF)

Dose escalated CHOP + etoposide and repetitive autologous stem cell transplantation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6654-6654

2005

Volltextzugriff (PDF)

Bi-weekly dosing preserves the efficacy of rituximab in elderly patients with poor-prognosis DLBCL: Results from the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study group (DSHNHL)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7536-7536

2006

Volltextzugriff (PDF)

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2551-2551

2006

Volltextzugriff (PDF)

Functional tumor reactive T cells in bone marrow and blood of pancreatic cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4113-4113

2005

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

KollektionOxford journals

Zeitschrift / SerieNuclear Physics. A

SpracheEstnisch

PublikationsformBuchkapitel

ThemaHumans

ThemaProtons

ThemaScience & Technology

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Cancer Research
(1)
Oncology
(1)

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of immunocytology to predict bladder cancer presence in patients with asymptomatic hematuria

WISER survivor: Exercise and/or weight loss in breast cancer survivors

Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M

Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA

Impact of older age on chemotherapy toxicity and quality of life in women with advanced or recurrent cervical cancer: A NRG Oncology-GOG Ancillary Study

First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M

Aggressive craniofacial lymphoma in the pre-rituximab and rituximab era

Evidence for rituximab (R) underdosing in subpopulations of elderly patients with DLBC: Results of the RICOVER-60 study of the DSHNHL

Identification of 46 quality indicators for cancer care in office-based oncology practices in Germany

The impact of high-intensity conditioning prior to allogeneic stem cell transplantation in patients with chemorefractory or relapsed T-cell lymphoma

Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis

Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20 + B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL

Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: Final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphona Study Group (DSHNHL)

Prevention of palmoplantar erythrodysesthesia (PPE) with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (PLD), a placebo-controlled, double blinded, phase lll trial (SAKK 92/08)

Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy

Mature T-/NK-cell lymphomas: Prognostic factors and treatment outcome of patients treated on studies of the German High-Grade Lymphoma Study Group (DSHNHL)

R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by autologous stem cell transplantation: CORAL study

Prophylactic oral glutamine for docetaxel or paclitaxel associated taste alterations in cancer patients: A randomised, parallel, placebo-controlled, double-blind study

Dose escalated CHOP + etoposide and repetitive autologous stem cell transplantation (MegaCHOEP) with and without rituximab for primary treatment of aggressive NHL

Bi-weekly dosing preserves the efficacy of rituximab in elderly patients with poor-prognosis DLBCL: Results from the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study group (DSHNHL)

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial

Functional tumor reactive T cells in bone marrow and blood of pancreatic cancer patients

Aktive Filter

Suchergebnisse filtern